Patient Safety Organizations: Delisting for Cause of Patient Safety Organization One, Inc., 58812-58813 [2011-24100]

Download as PDF 58812 Federal Register / Vol. 76, No. 184 / Thursday, September 22, 2011 / Notices must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than October 17, 2011. A. Federal Reserve Bank of Philadelphia (William Lang, Senior Vice President) 100 North 6th Street, Philadelphia, Pennsylvania 19105– 1521: 1. Polonia MHC, Huntingdon Valley, Pennsylvania; to convert to stock form and merge with Polonia Bancorp, Inc., Baltimore, Maryland, which proposes to become a savings and loan holding company by acquiring Polonia Bank, Huntingdon Valley, Pennsylvania. In connection with this application, Polonia Bancorp, Inc., has applied to become a bank holding company. B. Federal Reserve Bank of Cleveland (Nadine Wallman, Vice President) 1455 East Sixth Street, Cleveland, Ohio 44101–2566: 1. Cheviot Mutual Company, Cheviot, Ohio; to convert to stock form and acquire Cheviot Savings Bank, Cheviot, Ohio. Pursuant to the conversion, Cheviot, Mutual Holding Company and Cheviot Financial Corp., the existing federal mid-tier corporation, will cease to exist, and Cheviot Savings Bank will become a wholly owned subsidiary of Cheviot Financial Corp., Cheviot, Ohio, a Maryland corporation. In addition, Cheviot Financial Corp., the Maryland corporation, has applied to acquire Cheviot Savings Bank. Board of Governors of the Federal Reserve System, September 19, 2011. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. 2011–24388 Filed 9–21–11; 8:45 am] these activities will be conducted throughout the United States. Each notice is available for inspection at the Federal Reserve Bank indicated. The notice also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the question whether the proposal complies with the standards of section 10a(c)(4)(B) of HOLA (12.U.S.C. 1467a(c)(4)(B)). Unless otherwise noted, comments regarding the applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than October 7, 2011. A. Federal Reserve Bank of Dallas (E. Ann Worthy, Vice President) 2200 North Pearl Street, Dallas, Texas 75201– 2272: 1. AF Mutual Holding Company, and Alamogordo Financial Corp, both of Alamogordo, New Mexico; to engage de novo through Bank’34, Alamogordo, New Mexico, in acquiring and holding foreclosed property, nonperforming assets, and/or substandard assets currently held by Bank ’34, pursuant to section 238.54 of Regulation MM. Board of Governors of the Federal Reserve System, September 19, 2011. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. 2011–24387 Filed 9–21–11; 8:45 am] BILLING CODE 6210–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality BILLING CODE 6210–01–P Patient Safety Organizations: Delisting for Cause of Patient Safety Organization One, Inc. FEDERAL RESERVE SYSTEM jlentini on DSK4TPTVN1PROD with NOTICES Notice of Proposals To Engage in Permissible Nonbanking Activities or To Acquire Companies That Are Engaged in Permissible Nonbanking Activities The companies listed in this notice have given notice under the Home Owners’ Loan Act (HOLA) (12 U.S.C. 1461 et seq.), and Regulation LL (12 CFR part 238) or Regulation MM (12 CFR part 239) to engage de novo, or to acquire or control voting securities or assets of a company, including the companies listed below, that engages either directly or through a subsidiary or other company, in a nonbanking activity that is described in §§ 238.53 or 238.54 of Regulation LL (12 CFR 238.53 or 238.54) or § 239.8 of Regulation MM (12 CFR 239.8). Unless otherwise noted, VerDate Mar<15>2010 17:29 Sep 21, 2011 Jkt 223001 Agency for Healthcare Research and Quality (AHRQ), HHS. ACTION: Notice of Delisting. AGENCY: Patient Safety Organization One, Inc.: AHRQ has delisted Patient Safety Organization One, Inc. as a Patient Safety Organization (PSO) pursuant to 42 CFR 3.108(b). The Patient Safety and Quality Improvement Act of 2005 (Patient Safety Act), Pub. L. 109–41, 42 U.S.C. 299b–21—b–26, provides for the formation of PSOs, which collect, aggregate, and analyze confidential information regarding the quality and safety of health care delivery. The Patient Safety and Quality Improvement Final Rule (Patient Safety Rule), 42 CFR part authorizes AHRQ, on behalf of the Secretary of HHS, to list as a PSO an entity that attests that it meets SUMMARY: PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 the statutory and regulatory requirements for listing. A PSO can be ‘‘delisted’’ by the Secretary if it is found to no longer meet the requirements of the Patient Safety Act and Patient Safety Rule. DATES: The delisting was effective at 12 Midnight ET (2400) on July 5, 2011. ADDRESSES: The directories of both listed and delisted PSOs can be accessed electronically at the following HHS Web site: https:// www.pso.AHRQ.gov/. FOR FURTHER INFORMATION CONTACT: Diane Cousins, RPh., Center for Quality Improvement and Patient Safety, AHRQ, 540 Gaither Road, Rockville, MD 20850; Telephone (toll free): (866) 403–3697; Telephone (local): (301) 427–1111; TTY (toll free): (866) 438–7231; TTY (local): (301) 427–1130; E-mail: pso@AHRQ.hhs.gov. SUPPLEMENTARY INFORMATION: Background The Patient Safety Act authorizes the listing of PSOs, which are entities or component organizations whose mission and primary activity is to conduct activities to improve patient safety and the quality of health care delivery. HHS issued the Patient Safety Rule to implement the Patient Safety Act. AHRQ administers the provisions of the Patient Safety Act and Patient Safety Rule (PDF file, 450 KB. PDF Help) relating to the listing and operation of PSOs. Section 3.108(d) of the Patient Safety Rule requires AHRQ to provide public notice when it removes an organization from the list of federally approved PSOs. Patient Safety Organization One, Inc. failed to respond to two findings of deficiency contained in a Notice of Proposed Revocation and Delisting: (1) Failure to provide required notification to AHRQ that the PSO has complied with the requirement of entering into two Patient Safety Act contracts within 24-months of the date of initial listing, as required by 42 U.S.C. 299b– 24(b)(1)(C); and (2) failure to submit information necessary for AHRQ to conduct a compliance assessment of the PSO, as required by 42 CFR 3.110. Patient Safety Organization One, Inc. has not responded to either preliminary notice of deficiency sent by AHRQ pursuant to 42 CFR 3.108(a)(2), nor provided any evidence of a good faith effort to correct either deficiency. Accordingly, pursuant to 42 CFR 3.108(b), AHRQ delisted Patient Safety Organization One, Inc., PSO number P0059, effective at 12:00 Midnight ET (2400) on July 5, 2011. E:\FR\FM\22SEN1.SGM 22SEN1 Federal Register / Vol. 76, No. 184 / Thursday, September 22, 2011 / Notices More information on PSOs can be obtained through AHRQ’s PSO Web site at https://www.pso.AHRQ.gov/ index.html. [FR Doc. 2011–24100 Filed 9–21–11; 8:45 am] BILLING CODE 4160–90–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2009–D–0271] Guidance for Industry; Measures to Address the Risk for Contamination by Salmonella Species in Food Containing a Pistachio-Derived Product as an Ingredient; Availability Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing the availability of a guidance entitled ‘‘Guidance for Industry: Measures to Address the Risk for Contamination by Salmonella Species in Food Containing a Pistachio-Derived Product as an Ingredient.’’ The guidance clarifies for manufacturers who produce foods containing a pistachio-derived product as an ingredient that there is a risk that Salmonella species may be present in the incoming pistachio-derived product, and recommends measures to address that risk. DATES: Submit either electronic or written comments on Agency guidances at any time. ADDRESSES: Submit written requests for single copies of the guidance to the Division of Plant and Dairy Food Safety, Center for Food Safety and Applied Nutrition (HFS–317), Food and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD 20740. Send two self-addressed adhesive labels to assist that office in processing your request. See the SUPPLEMENTARY INFORMATION section for electronic access to the guidance. Submit electronic comments on the guidance to https://www.regulations.gov. Submit written comments on the guidance to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. FOR FURTHER INFORMATION CONTACT: Michael E. Kashtock, Center for Food Safety and Applied Nutrition (HFS– 317), Food and Drug Administration, jlentini on DSK4TPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 17:29 Sep 21, 2011 SUPPLEMENTARY INFORMATION: Jkt 223001 BILLING CODE 4160–01–P In the Federal Register of June 29, 2009 (74 FR 31038), FDA announced the availability of a draft guidance entitled ‘‘Guidance for Industry: Measures to Address the Risk for Contamination by Salmonella Species in Food Containing a Pistachio-Derived Product as an Ingredient’’ and gave interested parties an opportunity to submit comments by August 28, 2009. The Agency reviewed and evaluated these comments and has modified the guidance where appropriate. The guidance clarifies for manufacturers who produce foods containing a pistachio-derived product as an ingredient that there is a risk that Salmonella species may be present in the incoming pistachio-derived product, and recommends measures to address that risk. Pistachio-derived products include roasted in-shell pistachios and shelled pistachios (also called kernels) that are roasted or raw. FDA is issuing this guidance as level 1 guidance consistent with FDA’s good guidance practices regulation (21 CFR 10.115). The guidance represents the Agency’s current thinking on measures to address the risk for contamination by Salmonella spp. in food containing a pistachio-derived product as an ingredient. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. An alternate approach may be used if such approach satisfies the requirements of the applicable statutes and regulations. II. Comments Interested persons may submit to the Division of Dockets Management (see ADDRESSES) either electronic or written comments regarding the guidance. It is only necessary to send one set of comments. It is no longer necessary to send two copies of mailed comments. Identify comments with the docket number found in brackets in the heading of this document. Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. III. Electronic Access Persons with access to the Internet may obtain the guidance at https:// www.fda.gov/FoodGuidances or https:// www.regulations.gov. PO 00000 Frm 00047 Fmt 4703 Dated: September 16, 2011. Leslie Kux, Acting Assistant Commissioner for Policy. [FR Doc. 2011–24317 Filed 9–21–11; 8:45 am] I. Background Dated: September 8, 2011 Carolyn M. Clancy, Director. AGENCY: 5100 Paint Branch Pkwy., College Park, MD 20740, 240–402–2022. 58813 Sfmt 4703 DEPARTMENT OF HOMELAND SECURITY [Docket No. DHS–2011–0096] Homeland Security Advisory Council The Office of Policy, DHS. Notice of open teleconference Federal Advisory Committee meeting. AGENCY: ACTION: The Homeland Security Advisory Council (HSAC) will meet via teleconference for the purpose of reviewing and deliberating on recommendations by the HSAC’s Southwest Border Task Force. DATES: The HSAC conference call will take place from 4 p.m. to 5 p.m. EDT on Monday, October 17, 2011. Please be advised that the meeting is scheduled for one hour and may end early if all business is completed before 5 p.m. ADDRESSES: The HSAC meeting will be held via teleconference. Members of the public interested in participating in this teleconference meeting may do so by following the process outlined below (see ‘‘Public Participation’’). Written comments must be submitted and received by October 14, 2011. Comments must be identified by Docket No. DHS–2011–0096 and may be submitted by one of the following methods: • Federal eRulemaking Portal: https:// www.regulations.gov. Follow the instructions for submitting comments. • E-mail: HSAC@dhs.gov. Include docket number in the subject line of the message. • Fax: (202) 282–9207 • Mail: Homeland Security Advisory Council, Department of Homeland Security, Mailstop 0445, 245 Murray Lane, SW., Washington, DC 20528. Instructions: All submissions received must include the words ‘‘Department of Homeland Security’’ and DHS–2011– 0096, the docket number for this action. Comments received will be posted without alteration at https:// www.regulations.gov, including any personal information provided. Docket: For access to the docket to read comments received by the DHS Homeland Security Advisory Council, go to https://www.regulations.gov. FOR FURTHER INFORMATION CONTACT: Pat McQuillan at hsac@dhs.gov or 202–447– 3135. SUMMARY: E:\FR\FM\22SEN1.SGM 22SEN1

Agencies

[Federal Register Volume 76, Number 184 (Thursday, September 22, 2011)]
[Notices]
[Pages 58812-58813]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-24100]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Patient Safety Organizations: Delisting for Cause of Patient 
Safety Organization One, Inc.

AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.

ACTION: Notice of Delisting.

-----------------------------------------------------------------------

SUMMARY: Patient Safety Organization One, Inc.: AHRQ has delisted 
Patient Safety Organization One, Inc. as a Patient Safety Organization 
(PSO) pursuant to 42 CFR 3.108(b). The Patient Safety and Quality 
Improvement Act of 2005 (Patient Safety Act), Pub. L. 109-41, 42 U.S.C. 
299b-21--b-26, provides for the formation of PSOs, which collect, 
aggregate, and analyze confidential information regarding the quality 
and safety of health care delivery. The Patient Safety and Quality 
Improvement Final Rule (Patient Safety Rule), 42 CFR part authorizes 
AHRQ, on behalf of the Secretary of HHS, to list as a PSO an entity 
that attests that it meets the statutory and regulatory requirements 
for listing.
    A PSO can be ``delisted'' by the Secretary if it is found to no 
longer meet the requirements of the Patient Safety Act and Patient 
Safety Rule.

DATES: The delisting was effective at 12 Midnight ET (2400) on July 5, 
2011.

ADDRESSES: The directories of both listed and delisted PSOs can be 
accessed electronically at the following HHS Web site: https://www.pso.AHRQ.gov/.

FOR FURTHER INFORMATION CONTACT: Diane Cousins, RPh., Center for 
Quality Improvement and Patient Safety, AHRQ, 540 Gaither Road, 
Rockville, MD 20850; Telephone (toll free): (866) 403-3697; Telephone 
(local): (301) 427-1111; TTY (toll free): (866) 438-7231; TTY (local): 
(301) 427-1130; E-mail: pso@AHRQ.hhs.gov.

SUPPLEMENTARY INFORMATION: 

Background

    The Patient Safety Act authorizes the listing of PSOs, which are 
entities or component organizations whose mission and primary activity 
is to conduct activities to improve patient safety and the quality of 
health care delivery. HHS issued the Patient Safety Rule to implement 
the Patient Safety Act. AHRQ administers the provisions of the Patient 
Safety Act and Patient Safety Rule (PDF file, 450 KB. PDF Help) 
relating to the listing and operation of PSOs. Section 3.108(d) of the 
Patient Safety Rule requires AHRQ to provide public notice when it 
removes an organization from the list of federally approved PSOs.
    Patient Safety Organization One, Inc. failed to respond to two 
findings of deficiency contained in a Notice of Proposed Revocation and 
Delisting: (1) Failure to provide required notification to AHRQ that 
the PSO has complied with the requirement of entering into two Patient 
Safety Act contracts within 24-months of the date of initial listing, 
as required by 42 U.S.C. 299b-24(b)(1)(C); and (2) failure to submit 
information necessary for AHRQ to conduct a compliance assessment of 
the PSO, as required by 42 CFR 3.110. Patient Safety Organization One, 
Inc. has not responded to either preliminary notice of deficiency sent 
by AHRQ pursuant to 42 CFR 3.108(a)(2), nor provided any evidence of a 
good faith effort to correct either deficiency. Accordingly, pursuant 
to 42 CFR 3.108(b), AHRQ delisted Patient Safety Organization One, 
Inc., PSO number P0059, effective at 12:00 Midnight ET (2400) on July 
5, 2011.

[[Page 58813]]

    More information on PSOs can be obtained through AHRQ's PSO Web 
site at https://www.pso.AHRQ.gov/.

    Dated: September 8, 2011
Carolyn M. Clancy,
Director.
[FR Doc. 2011-24100 Filed 9-21-11; 8:45 am]
BILLING CODE 4160-90-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.